<?xml version="1.0" encoding="UTF-8"?>
<fig id="F0005" orientation="portrait" position="float">
 <label>Figure 5.</label>
 <caption>
  <p>Blocking ZIKV cellular attachment to Hsp70 reduces cell infection rates and infectious particle production. (A) Antibody blocking of Hsp70 reduces Huh7.5 cellular infection with ZIKV. Axl antibody = positive control for blocking. Isotype antibody and beta-actin antibody = negative controls. After antibody treatment, cells were infected with ZIKV and plaque reduction neutralization assay performed. (B) Competition of ZIKV with recombinant human Hsp70 protein (rhHsp70) reduces Huh7.5 cellular infection with ZIKV. Control cells were treated with bovine serum albumin (BSA). Error bars denote 95% confidence intervals. NS = not significant.</p>
 </caption>
 <alternatives>
  <graphic specific-use="web-only" content-type="black-white" xlink:href="TEMI_A_1557988_F0005_OB" xmlns:xlink="http://www.w3.org/1999/xlink"/>
  <graphic specific-use="print-only" content-type="black-white" xlink:href="TEMI_A_1557988_F0005_PB" xmlns:xlink="http://www.w3.org/1999/xlink"/>
 </alternatives>
</fig>
